SurgiTech, LLC and Amendia, Inc. Enter Into a Agreement for the Rights to SurgiFile® Spinal Decompression System (press release)
SurgiTech, LLC, and Amendia, Inc., a manufacturer and distributor of spinal implants and surgical instruments, announce that they have entered into a license agreement for the patented SurgiFile® Spinal Decompression System.
“We are pleased to partner exclusively with Amendia on spinal applications of SurgiFile and will continue to pursue other applications such as total joint reconstruction, trauma and sports medicine for this platform technology.”
The SurgiFile product uses proprietary technology to selectively cut bone while safely preserving healthy spinal tissue. The SurgiFile is well suited for use in both open and minimally invasive surgical procedures where the surgical site is difficult to access. During spinal decompression surgery, the SurgiFile is highly effective at removing stenotic bone while preserving the stabilizing bony structures and protecting neural and other soft tissues.
“We are proud to offer the SurgiFile as a key component of Amendia’s leading medical and surgical products portfolio. Patient comfort, ease of surgery, and improved surgical outcomes drive our product selection. The SurgiFile propels Amendia’s minimally invasive product portfolio into the growing spinal decompression market,” said Jeff Smith, CEO of Amendia.
“We are pleased to partner with Amendia because of their growing market penetration, strategic business alliances, and their focus on solutions for minimally invasive spinal surgery. They fully understand the product and its potential to make a difference in patient outcomes,” stated Wade Fallin, CEO of SurgiTech. “We are pleased to partner exclusively with Amendia on spinal applications of SurgiFile and will continue to pursue other applications such as total joint reconstruction, trauma and sports medicine for this platform technology.”
About SurgiTech
SurgiTech is a privately held, early stage medical device company that develops innovative, powered cutting instruments that enable surgeons to perform bone removal faster, safer, and with more precision and control. SurgiTech’s key investors and board members include VentureMD, an angel capital firm and business incubator, and Medtech Catalyst, LLC, a marketing and strategic management firm.
About Amendia
Headquartered in Marietta, Georgia, Amendia is a leading provider of innovative Class II and Class III medical devices used in spine surgery, including spinal fixation systems, implants, and instruments. Through extensive relationships developed by Amendia internationally with private and public counterparts, Amendia is a leader in the rapidly growing minimally-invasive surgical device sector. Amendia markets its state-of-the-art medical implants and surgical devices primarily through direct sales to leading orthopaedic and neurological centers and prominent distributors throughout the country.
Contacts
SurgiTech:
Mr. Wade Fallin, 800-230-3710
wade@venturemd.com
or
Amendia:
Mr. Jeff Smith, 770-575-5220
Chief Executive Officer
jsmith@amendia.com